Related Experiment Video
Updated: Jun 3, 2025

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Biventricular dysfunction predicts mortality in ST elevation myocardial infarction patients with cardiogenic shock
Angga Dwi Prasetyo1, Hendry Purnasidha Bagaswoto2, Firandi Saputra1
1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Jalan Farmako Sekip Utara, Yogyakarta, 55281, Indonesia.
Insights
Biventricular dysfunction significantly increases in-hospital mortality risk in ST-elevation myocardial infarction (STEMI) patients experiencing cardiogenic shock. Other mortality predictors include renal failure and vasopressor use.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Clinical Research
Background:
- Mortality in cardiogenic shock due to ST-elevation myocardial infarction (STEMI) remains high despite reperfusion therapy.
- Ventricular systolic dysfunction is a primary cause of cardiogenic shock in STEMI.
- While left and right ventricular dysfunction have been studied, the predictive value of biventricular dysfunction for mortality is unclear.
Purpose of the Study:
- To evaluate the mortality predictive value of biventricular systolic dysfunction in STEMI patients with cardiogenic shock.
- To identify key predictors of in-hospital mortality in this patient population.
Main Methods:
- Retrospective cohort study using the Sardjito Cardiovascular Intensive Care (SCIENCE) registry.
- Data collected from November 2021 to September 2023 at Dr. Sardjito General Hospital.
- Multivariate logistic regression analysis to assess predictors of in-hospital mortality.
Main Results:
- Biventricular dysfunction (BVD) significantly increases the risk of in-hospital mortality (OR, 1.771; p=0.016).
- Other significant mortality predictors include renal failure (OR, 5.122; p<0.001) and inotropic/vasopressor use (OR, 6.876; p<0.001).
- Percutaneous coronary intervention (PCI) was associated with reduced mortality (OR, 0.493; p=0.044).
Conclusions:
- Biventricular dysfunction is a significant independent predictor of in-hospital mortality in STEMI patients with cardiogenic shock.
- Renal failure and the need for inotropic or vasopressor support are critical factors influencing mortality.
- PCI may play a protective role in reducing mortality in this cohort.
Background:
The incidence of mortality in patients with cardiogenic shock due to ST elevation myocardial infarction (STEMI) remains high even with prompt reperfusion therapy. Ventricular systolic dysfunction is the primary condition causing cardiogenic shock in STEMI. Studies have been widely conducted on the left ventricle (LV) and right ventricle (RV) systolic dysfunction related to mortality events. However, the parameters of biventricular systolic dysfunction predicting mortality as a stronger predictor of mortality are still unclear. Accordingly, we evaluated the predictor mortality value of biventricular systolic dysfunction in STEMI patients with cardiogenic shocks. Based on The Society for Cardiovascular Angiography and Intervention classification, we analyzed data from November 2021 to September 2023 at Dr. Sardjito General Hospital in Yogyakarta, Indonesia, using the Sardjito Cardiovascular Intensive Care (SCIENCE) registry with a retrospective cohort design. Multivariate logistic regression analysis was used to assess predictors of in-hospital mortality.
Results:
There were 1,059 subjects with a mean ± SD age of 59 ± 11 years, dominated by men (80.5%) who met the inclusion and exclusion criteria. Based on multivariate analysis, biventricular dysfunction (BVD) is a factor that significantly increases the risk of in-hospital mortality (Odds ratio [OR], 1.771: 95% confidence interval [CI] 1.113-2.819; p = 0.016). Other significant factors affecting mortality were renal failure (OR, 5.122; 95% CI 3.233-8.116; p < 0.001), percutaneous coronary intervention (PCI) (OR, 0.493; 95% CI 0.248-0.981; p = 0.044), and inotropic/vasopressor (OR, 6.876; 95% CI 4.583-10.315; p < 0.001).
Conclusions:
Biventricular dysfunction significantly increases the risk of in-hospital mortality in STEMI patients with cardiogenic shock. Renal failure, PCI, and the requirement for inotropic or vasopressor drugs are also factors that influence in-hospital mortality.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pathophysiology of Heart Failure
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Heart Failure Drugs: Inotropic Agents

